Dermatology

Innovator or Biosimilar for a Patient with Psoriasis

Array

Activity Info

Upon completion of the activity, participants should be able to:
1. Explain to patients and peers the scientific rationale and empirical data with biosimilars that make them as safe and effective as their biologic originators for dermatologic conditions
2. Explain the circumstances under which it is appropriate to initiate or switch a patient with psoriasis to a biosimilar
Email

CME/CE credit is no longer available for this activity.

Tags

Webinar | 0.50 - 30 mins | Dermatology | Internal Medicine | Family Medicine | Nurse | Biosimilars | BiosimilarsCME.org | Online | Pharmacist |